Samsara is the IBD Stock of the Day ahead of its Q4 earnings report due March 6. Samara stock has forged a cup base, rebounding from a sell-off.
The Magnificent Seven are still under the spotlight, but it may be time for investors to look beyond the dominant tech titans ...
A new twist on value has investors waking up to the beauty of companies returning gobs of cash to shareholders.
Taser maker Axon sees AI-related sales take off and its drone business gain momentum. Axon stock is near a buy point.
The stock of Meta Platforms (META) is on a record 15-day win streak.Maximize Your Portfolio with Data Driven Insights:Leverage the power of ...
Goldman has previously explained that Phase 3 companies are those with the potential to monetize AI through generating incremental revenues, mostly in software and IT services. Phase 2 represents the ...
Alphabet and Amazon.com were the latest among Magnificent Seven tech stocks to fall short of guidance forecasts, weighing on ...
US stocks mostly gain early Thursday as investors weigh earnings reports. Amazon results are due after the close and monthly ...
The debut of writer-director Glorimar Marrero Sánchez is set to debut in U.S. theaters in March 2025, coinciding with Puerto ...
DeepSeek’s AI has Silicon Valley on edge, leaving law firms scrambling to balance opportunity, privacy risks, and considering ...
Software stocks look set to benefit from the DeepSeek implications, as cheaper AI could boost revenue momentum this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results